ARG1 and neoplasm: In CRC, neutrophils exhibit a dual role: in early-stage tumors or under specific therapies, they may trigger cytotoxic effects against tumor cells, while in advanced stages, they are more likely to employ ROS and arginase-1 to suppress T-cell activity and promote a pro-metastatic niche.